Literature DB >> 23525529

B-type natriuretic peptide is not a volume marker among patients on hemodialysis.

Rajiv Agarwal1.   

Abstract

BACKGROUND: Although the cardiac biomarker B-type natriuretic peptide (BNP) is strongly related to mortality in end-stage renal disease (ESRD), whether it is a predictor of weight change or blood pressure (BP) response upon probing dry weight among hypertensive hemodialysis patients remains unknown. The purpose of this study was to examine among people with hypertension on hemodialysis whether BNP is a biomarker of excess volume.
METHODS: Hypertensive hemodialysis patients (n = 150) were randomized to a control group (n = 50) or an ultrafiltration group (n = 100) and followed up for 30 dialysis treatments. After a baseline run-in of six treatments, those assigned to the ultrafiltration group had dry weight probed over 8 weeks. Forty-four-hour interdialytic ambulatory BP and predialysis BNP were measured at the end of run-in period, at 4 weeks and at 8 weeks.
RESULTS: The median BNP concentration was 93 pg/mL (interquartile range 31-257 pg/mL). The magnitude of decline in the BNP depended on the baseline concentration of BNP, but did not require probing dry weight or weight loss. No relationship existed between decline in postdialysis weight upon probing dry weight and baseline BNP. Furthermore, reduction in the BNP was not required for decline in postdialysis weight. Predialysis log BNP modestly predicted ambulatory systolic and pulse pressure independently of other risk factors. No relationship was found between decline in BP upon probing dry weight and baseline BNP. Upon probing dry weight, reduction in BNP was not required for decline in systolic ambulatory BP.
CONCLUSION: Taken together, these data suggest that among hypertensive patients on hemodialysis BNP is not a volume marker.

Entities:  

Keywords:  BNP; ESRD; dry weight; hemodialysis; hypertension

Mesh:

Substances:

Year:  2013        PMID: 23525529      PMCID: PMC3843342          DOI: 10.1093/ndt/gft054

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  27 in total

1.  Volume status and blood pressure during long-term hemodialysis: role of ventricular stiffness.

Authors:  Chen-Huan Chen; Yao-Ping Lin; Wen-Chung Yu; Wu-Chang Yang; Yu-An Ding
Journal:  Hypertension       Date:  2003-07-28       Impact factor: 10.190

2.  The postdialytic plasma cyclic guanosine 3':5'-monophosphate level as a measure of fluid overload in chronic hemodialysis.

Authors:  F Lauster; H J Fülle; R Gerzer; H Schiffl
Journal:  J Am Soc Nephrol       Date:  1992-03       Impact factor: 10.121

3.  Why assistive technology is needed for probing of dry weight.

Authors:  Arjun D Sinha
Journal:  Blood Purif       Date:  2011-01-10       Impact factor: 2.614

4.  Assessment of dry body-weight in haemodialysis patients by the biochemical marker cGMP.

Authors:  F Lauster; R Gerzer; J Weil; H J Fülle; H Schiffl
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

5.  Echography of the inferior vena cava is a simple and reliable tool for estimation of 'dry weight' in haemodialysis patients.

Authors:  E C Cheriex; K M Leunissen; J H Janssen; J M Mooy; J P van Hooff
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

6.  Diagnostic potential of cardiac natriuretic peptides in dialysis patients.

Authors:  F Mallamaci; C Zoccali; G Tripepi; F A Benedetto; S Parlongo; A Cataliotti; S Cutrupi; G Giacone; I Bellanuova; B Stancanelli; L S Malatino
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

7.  Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient.

Authors:  Seoung Woo Lee; Joon Ho Song; Gyeong A Kim; Hee Jung Lim; Moon-Jae Kim
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

8.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690

9.  Association between brain natriuretic peptide and extracellular water in hemodialysis patients.

Authors:  Riccardo Maria Fagugli; Barbara Palumbo; Daniela Ricciardi; Paolo Pasini; Paola Santirosi; Luigi Vecchi; Franca Pasticci; Renato Palumbo
Journal:  Nephron Clin Pract       Date:  2003

10.  Plasma alpha-human atrial natriuretic peptide and volume status in chronic haemodialysis patients.

Authors:  K M Leunissen; P P Menheere; E C Cheriex; B W van den Berg; T C Noordzij; J P van Hooff
Journal:  Nephrol Dial Transplant       Date:  1989       Impact factor: 5.992

View more
  9 in total

1.  Brain Natriuretic Peptide Is a Marker of Fluid Overload in Incident Hemodialysis Patients.

Authors:  Charles Chazot; Margaux Rozes; Cyril Vo-Van; Patrik Deleaval; Jean-Marc Hurot; Christie Lorriaux; Brice Mayor; Eric Zaoui; Guillaume Jean
Journal:  Cardiorenal Med       Date:  2017-04-29       Impact factor: 2.041

Review 2.  Do Natriuretic Peptide Measurements Provide Insights into Management of End-Stage Renal Disease Patients Undergoing Dialysis?

Authors:  Thanat Chaikijurajai; Hernan Rincon Choles; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-09-17

3.  Comparison of hydration and nutritional status between young and elderly hemodialysis patients through bioimpedance analysis.

Authors:  Jung Eun Lee; In Young Jo; Song Mi Lee; Woo Jeong Kim; Hoon Young Choi; Sung Kyu Ha; Hyung Jong Kim; Hyeong Cheon Park
Journal:  Clin Interv Aging       Date:  2015-08-13       Impact factor: 4.458

4.  Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide measurement.

Authors:  Haiyan Chen; Buyun Wu; Dehua Gong; Zhihong Liu
Journal:  Crit Care       Date:  2015-04-02       Impact factor: 9.097

5.  Predictive abilities of baseline measurements of fluid overload, assessed by bioimpedance spectroscopy and serum N-terminal pro-B-type natriuretic peptide, for mortality in hemodialysis patients.

Authors:  Ianis Siriopol; Dimitrie Siriopol; Luminita Voroneanu; Adrian Covic
Journal:  Arch Med Sci       Date:  2017-07-19       Impact factor: 3.318

6.  Use of body composition measurements to guide the assessment of dry weight in anuric dialysis patients: improvements in blood pressure control.

Authors:  GuoCun Hou; Hua Gan; XiuLi Sun; Jing Li
Journal:  Biochem Biophys Rep       Date:  2019-01-24

7.  Brain natriuretic peptide reflects individual variation in hydration status in hemodialysis patients.

Authors:  Jenny Stenberg; Jan Melin; Magnus Lindberg; Hans Furuland
Journal:  Hemodial Int       Date:  2019-03-07       Impact factor: 1.812

8.  Are there any further modalities for prediction of subclinical volume overload in advanced stages of chronic kidney disease?

Authors:  Aber Halim Baki; Cherry Reda Kamel; Hazem Mansour
Journal:  Kidney Res Clin Pract       Date:  2021-02-02

9.  Relative Change of Protidemia Level Predicts Intradialytic Hypotension.

Authors:  Maureen Assayag; David Levy; Pascal Seris; Catherine Maheas; Anne-Lyse Langlois; Kamal Moubakir; Sophie Laplanche; Christophe Ridel; Maxime Touzot
Journal:  J Am Heart Assoc       Date:  2020-01-06       Impact factor: 5.501

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.